Covalon Reports Fiscal 2026 Third Quarter Results With Significant Margin Expansion

Covalon Technologies reported strong fiscal 2026 third quarter results on June 30, 2026, with gross margins surging to 67.2% from 46.5% a year earlier Leader Post. Earnings per share doubled to $0.10 versus the prior quarter, while the company ended the period with $19.4 million in cash and zero bank debt Owen Sound Sun Times.
The medical device maker's Contamination Protection revenue jumped 68% year-over-year and 34% sequentially Montreal Gazette. Adjusted EBITDA reached $10.0 million—the highest quarterly figure in five fiscal years—as the company demonstrated accelerating profitability Chatham Daily News.
Covalon's gross margin expanded dramatically from 46.5% to 67.2% year-over-year Clinton News Record. This 20.7 percentage point improvement reflects stronger pricing power and operational efficiency. The gain signals the company's ability to scale profitably as revenue climbs.
Contamination Protection revenue surged 68% compared to the same quarter last year Fairview Post. The segment also grew 34% from the previous quarter, outpacing overall company performance. This sustained momentum suggests strong market demand for the division's core products.
Covalon closed the quarter with $19.4 million in cash, up $2.8 million from the prior quarter Leader Post. The company carries no bank debt, providing financial flexibility for growth investments. This clean balance sheet allows management to pursue strategic opportunities without leverage constraints.
Adjusted EBITDA reached $10.0 million in Q3 2026, the highest quarterly result in the past five fiscal years Owen Sound Sun Times. This metric shows the company's earnings power before interest, taxes, and non-cash charges. The achievement reflects both revenue growth and margin expansion driving profitability.
Publishers
6
Articles
6
Reach
6